These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2905774)

  • 41. Perinatal low-level lead exposure and the septo-hippocampal cholinergic system: selective reduction of muscarinic receptors and cholineacetyltransferase in the rat septum.
    Bielarczyk H; Tomsig JL; Suszkiw JB
    Brain Res; 1994 Apr; 643(1-2):211-7. PubMed ID: 8032916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deficits in cholinergic enzymes and muscarinic receptors in the hippocampus and striatum of senescent rats: effect of chronic hydergine treatment.
    Dravid AR
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):195-202. PubMed ID: 6639216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Muscarinic agonist receptor subtypes in aging rat brain.
    Briggs RS; Petersen MM; Cook PJ
    Neurobiol Aging; 1982; 3(3):259-61. PubMed ID: 7162554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemical effects of phosphatidylcholine treatment in rats.
    Jope RS; Jenden DJ; Subramanian CS; Dhopeshwarker GA; Duncan J
    Biochem Pharmacol; 1984 Mar; 33(5):793-8. PubMed ID: 6712709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Down-regulation of muscarinic receptors in the striatum of organophosphate-treated swine.
    Yang CM; Dwyer TM; Mohan PM; Ho IK; Farley JM
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):375-85. PubMed ID: 2385834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of electroconvulsive shock on muscarinic cholinergic receptors in rat cerebral cortex and hippocampus.
    Lerer B; Stanley M; Demetriou S; Gershon S
    J Neurochem; 1983 Dec; 41(6):1680-3. PubMed ID: 6644306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both.
    Meck WH; Smith RA; Williams CL
    Behav Neurosci; 1989 Dec; 103(6):1234-41. PubMed ID: 2610916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats.
    Pelham RW; Munsat TL
    Brain Res; 1979 Aug; 171(3):473-80. PubMed ID: 476482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of DDT, DDOH-palmitic acid, and a chlorinated paraffin on muscarinic receptors and the sodium-dependent choline uptake in the central nervous system of immature mice.
    Eriksson P; Nordberg A
    Toxicol Appl Pharmacol; 1986 Sep; 85(2):121-7. PubMed ID: 3764899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain muscarinic cholinergic receptor binding in Roman high- and low-avoidance rats.
    Overstreet DH; Driscoll P; Martin JR; Yamamura HI
    Psychopharmacology (Berl); 1981; 72(2):143-5. PubMed ID: 6782603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of in vivo binding properties of 3H-NMPB and 3H-QNB in mouse brain.
    Hosoi R; Kobayashi K; Watanabe Y; Inoue O
    J Neural Transm (Vienna); 1999; 106(7-8):583-92. PubMed ID: 10907719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muscarinic cholinergic receptors in the hippocampus of aged rats: influence of choline alphoscerate treatment.
    Amenta F; Liu A; Zeng YC; Zaccheo D
    Mech Ageing Dev; 1994 Oct; 76(1):49-64. PubMed ID: 7845062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age-related alterations in pre-synaptic and receptor-mediated cholinergic functions in rat brain.
    Büyükuysal RL; Ulus IH; Kiran BK
    Neurochem Res; 1998 May; 23(5):719-26. PubMed ID: 9566611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased density of beta-adrenergic and muscarinic cholinergic receptor sites in the vasa nervorum of aged rats.
    Zaccheo D; De Michele M; Mancini M; Amenta F
    Mech Ageing Dev; 1991 Nov; 60(3):255-65. PubMed ID: 1661357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.
    Lockhart B; Closier M; Howard K; Steward C; Lestage P
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):429-38. PubMed ID: 11330337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of phencyclidine on [3H]QNB binding.
    Boggan WO; Evans MG; Wallis CJ
    Life Sci; 1982 Apr; 30(14):1193-1200. PubMed ID: 7087659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Down-regulation of muscarinic receptors and the m3 subtype in white-footed mice by dietary exposure to parathion.
    Jett DA; Hill EF; Fernando JC; Eldefrawi ME; Eldefrawi AT
    J Toxicol Environ Health; 1993 Jul; 39(3):395-415. PubMed ID: 8350385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.